Veradigm Inc. Market Cap ($515.71 Million)
Market Cap & Net Worth: Veradigm Inc. (MDRX)
Veradigm Inc. market cap. Veradigm Inc. (NASDAQ:MDRX) has a market capitalization of $515.71 Million ($515.71 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11692 globally and #3000 in its home market, demonstrating a 1.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Veradigm Inc.'s stock price $4.85 by its total outstanding shares 108800000 (108.80 Million). Also see MDRX operating cash flow for how efficiently the company converts equity into cash flow.
Veradigm Inc. Market Cap History (2015–2026)
Veradigm Inc. market cap history from 2015 to 2026. Data shows change from $1.67 Billion to $527.79 Million (-9.02% CAGR). Check latest Veradigm Inc. stock price today for real-time trading data and today's change.
Veradigm Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Veradigm Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MDRX net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.75x
Veradigm Inc.'s market cap is 1.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.67 Billion | $1.39 Billion | -$2.23 Million | 1.21x | N/A |
| 2016 | $1.11 Billion | $1.55 Billion | -$25.65 Million | 0.72x | N/A |
| 2017 | $1.58 Billion | $1.50 Billion | -$196.46 Million | 1.06x | N/A |
| 2018 | $1.05 Billion | $1.75 Billion | $363.74 Million | 0.60x | 2.88x |
| 2019 | $1.07 Billion | $1.63 Billion | -$182.18 Million | 0.65x | N/A |
| 2020 | $1.57 Billion | $1.50 Billion | $700.41 Million | 1.05x | 2.24x |
| 2021 | $2.01 Billion | $577.43 Million | $134.44 Million | 3.48x | 14.93x |
| 2022 | $1.92 Billion | $588.02 Million | -$86.46 Million | 3.26x | N/A |
| 2024 | $1.03 Billion | $588.02 Million | -$86.46 Million | 1.75x | N/A |
Competitor Companies of MDRX by Market Capitalization
Companies near Veradigm Inc. in the global market cap rankings as of November 4, 2026. Also see Veradigm Inc. (MDRX) total assets for a full breakdown of the balance sheet.
Key companies related to Veradigm Inc. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #718 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1660 globally with a market cap of $14.14 Billion USD ( AU$19.99 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2013 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #718 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $303.21 |
| #1660 | Pro Medicus Ltd | AU:PME | $14.14 Billion | AU$191.33 |
| #2013 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $77.80 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $69.84 |
Market Capitalization of Veradigm Inc. (2015–2026)
Market capitalization of Veradigm Inc. from 2015 to today. Between 2015 and today, Veradigm Inc.'s market cap moved from $1.67 Billion to $ 527.79 Million, with a yearly change of -9.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $527.79 Million | +1.06% |
| 2025 | $522.24 Million | -49.21% |
| 2024 | $1.03 Billion | -9.91% |
| 2023 | $1.14 Billion | -40.53% |
| 2022 | $1.92 Billion | -4.39% |
| 2021 | $2.01 Billion | +27.77% |
| 2020 | $1.57 Billion | +47.12% |
| 2019 | $1.07 Billion | +1.82% |
| 2018 | $1.05 Billion | -33.75% |
| 2017 | $1.58 Billion | +42.51% |
| 2016 | $1.11 Billion | -33.62% |
| 2015 | $1.67 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Veradigm Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $515.71 Million USD |
| MoneyControl | $515.71 Million USD |
| MarketWatch | $515.71 Million USD |
| marketcap.company | $515.71 Million USD |
| Reuters | $515.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle se… Read more